Articles Tagged With: reuteri
-
Incretin and Insulin Secretion Improved in Non-Diabetic Individuals by Lactobacillus reuteri Supplementation
In this prospective, double-blind, randomized trial, the probiotic strain Lactobacillus reuteri SD5865 at a dosage of 1010 colony-forming units or placebo was provided to non-diabetic individuals twice daily for a period of four weeks to investigate the effect on various parameters associated with blood sugar handling, including secretion of insulin, C-peptide, and glucagon-like peptides-1 and -2.